Who Owns TRAW?

Traws Pharma, Inc. — Institutional Ownership & 13F Holdings

$1.16

+0.00 (+0.00%)

Market Cap

$8.0M

Shares Outstanding

7,990,870

Institutional Holders

19

Total Inst. Value

$4.0M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ORBIMED ADVISORS LLC$1.4M605,531
2PERCEPTIVE ADVISORS LLC$970K421,781
3ADAGE CAPITAL PARTNERS GP, L.L.C.$759K330,000
4Vestal Point Capital, LP$403K175,000
5Alyeska Investment Group, L.P.$121K52,630
6BOOTHBAY FUND MANAGEMENT, LLC$77K33,305
7GEODE CAPITAL MANAGEMENT, LLC$76K33,379
8Ikarian Capital, LLC$66K28,493
9UBS Group AG$33K14,323
10VANGUARD GROUP INC$29K13,173

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
Ikarian Capital, LLC-70K$66K
Alyeska Investment Group, L.P.-64K$121K
MORGAN STANLEY-15K$1K

Related Stocks

Frequently Asked Questions

How many institutional investors hold TRAW?

As of Q1 2025, 19 institutional investors report holding TRAW (Traws Pharma, Inc.) in their 13F filings.

Which hedge fund owns the most TRAW?

The largest institutional holder of TRAW is ORBIMED ADVISORS LLC with $1.4M in shares.

Are institutions buying or selling TRAW?

This quarter, 4 institutions opened new positions in TRAW and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.